Micropulse Treatment May Be Better Than Anti-VEGF In Treating Central Serous Chorioretinopathy

Ocular Surgery News

MicroPulse laser therapy may be superior to intravitreal bevacizumab injections in treating patients with central serous chorioretinopathy, according to a study.
  • <<
  • >>

Comments